Mortality Rates Remain Increased in Young Patients With Classical Hodgkin Lymphoma Even After Years in Remission: Results From a Nordic Lymphoma Group Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized Hovon-Nordic Lymphoma Group Phase Iii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma

Case Reports in Hematology
2016English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal
OncologyHematology
2016English

Lymphocyte-Rich Classical Hodgkin Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure – Polish Lymphoma Research Group Real-Life Experience

Acta Haematologica Polonica
OncologyHematology
2018English

An Anaplastic T-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie
Oncology
2016English

'Not So Classical': A Study of the Immunoprofile in Classical Hodgkin Lymphoma, an Experience From a Referral Center

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy